Cited by 27

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

STLV-1 as a model for studying HTLV-1 infection

Jégado, Brice, Kashanchi, Fatah, Dutartre, Hélène, Mahieux, Renaud·2019·Retrovirology

Abstract

Few years after HTLV-1 identification and isolation in humans, STLV-1, its simian counterpart, was discovered. It then became clear that STLV-1 is present almost in all simian species. Subsequent molecular epidemiology studies demonstrated that, apart from HTLV-1 subtype A, all human subtypes have a simian homolog. As HTLV-1, STLV-1 is the etiological agent of ATL, while no case of TSP/HAM has been described. Given its similarities with HTLV-1, STLV-1 represents a unique tool used for performing clinical studies, vaccine studies as well as basic science.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12977-019-0503-0

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Epidemiology of Simian T-Leukemia Virus Type-1 in wild-caught or captive non-human primates (NHPs) from Asia and Africa. All studies which reported STLV-1 infection in NHPs are listed. Orange and purple colors represent Asian and African STLV-1 infected NHPs, respectively. Countries with both colors and hatching represent Asian and African NHPs hosted in geographical areas where they are not naturally present
Fig. 1 Epidemiology of Simian T-Leukemia Virus Type-1 in wild-caught or captive non-human primates (NHPs) from Asia and Africa. All studies which reported STLV-1 infection in NHPs are listed. Orange and purple colors represent Asian and African STLV-1 infected NHPs, respectively. Countries with both colors and hatching represent Asian and African NHPs hosted in geographical areas where they are not naturally presentCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 123

  1. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA. 1980;77:7415–9. · DOI · Paper page
  2. Poiesz BJ, Ruscetti FW, Reitz MS, Kalyanaraman VS, Gallo RC. Isolation of a new type C retrovirus (HTLV) in primary uncultured cells of a patient with Sézary T-cell leukaemia. Nature. 1981;294:268–71. · DOI
  3. Takatsuki K, Uchiyama T, Sagawa K. Hattori T [Lymphoma and immunoglobulin abnormalities, with special reference to M proteinemia]. Nippon Rinsho. 1977;35:3757–67.
  4. Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood. 1977;50:481–92. · DOI
  5. Gallo RC. History of the discoveries of the first human retroviruses: HTLV-1 and HTLV-2. Oncogene. 2005;24:5926–30. · DOI
  6. Gessain A, Francis H, Sonan T, Giordano C, Akani F, Piquemal M, et al. HTLV-I and tropical spastic paraparesis in Africa. Lancet. 1986;2:698. · DOI
  7. Futsch N, Mahieux R, Dutartre H. HTLV-1, the other pathogenic yet neglected human retrovirus: from transmission to therapeutic treatment. Viruses. 2017;10:1. · DOI · Paper page
  8. Gessain A, Cassar O. Epidemiological aspects and world distribution of HTLV-1 infection. Front Microbiol. 2012;3:388. · DOI · Paper page
  9. Wattel E, Vartanian JP, Pannetier C, Wain-Hobson S. Clonal expansion of human T-cell leukemia virus type I-infected cells in asymptomatic and symptomatic carriers without malignancy. J Virol. 1995;69:2863–8. · DOI
  10. Mahieux R, Ibrahim F, Mauclere P, Herve V, Michel P, Tekaia F, et al. Molecular epidemiology of 58 new African human T-cell leukemia virus type 1 (HTLV-1) strains: identification of a new and distinct HTLV-1 molecular subtype in Central Africa and in pygmies. J Virol. 1997;71:17. · DOI
  11. Einsiedel L, Cassar O, Bardy P, Kearney D, Gessain A. Variant human T-cell lymphotropic virus type 1c and adult T-cell leukemia, Australia. Emerg Infect Dis. 2013;19:1639–41. · DOI
  12. Miyoshi I, Taguchi H, Fujishita M, Yoshimoto S, Kubonishi I, Ohtsuki Y, et al. Transformation of monkey lymphocytes with adult T-cell leukaemia virus. Lancet. 1982;1:1016. · DOI
  13. Miyoshi I, Yoshimoto S, Fujishita M, Taguchi H, Kubonishi I, Niiya K, et al. Natural adult T-cell leukemia virus infection in Japanese monkeys. Lancet. 1982;2:658. · DOI
  14. Hayami M, Komuro A, Nozawa K, Shotake T, Ishikawa K, Yamamoto K, et al. Prevalence of antibody to adult T-cell leukemia virus-associated antigens (ATLA) in Japanese monkeys and other non-human primates. Int J Cancer. 1984;33:179–83. · DOI
  15. Komuro A, Watanabe T, Miyoshi I, Hayami M, Tsujimoto H, Seiki M, et al. Detection and characterization of simian retroviruses homologous to human T-cell leukemia virus type I. Virology. 1984;138:373–8. · DOI
  16. Watanabe T, Seiki M, Hirayama Y, Yoshida M. Human T-cell leukemia virus type I is a member of the African subtype of simian viruses (STLV). Virology. 1986;148:385–8. · DOI
  17. Mossoun A, Calvignac-Spencer S, Anoh AE, Pauly MS, Driscoll DA, Michel AO, et al. Bushmeat hunting and zoonotic transmission of simian T-lymphotropic virus 1 in tropical West and Central Africa. J Virol. 2017;91:e02479-16. · DOI
  18. Kazanji M, Mouinga-Ondémé A, Lekana-Douki-Etenna S, Caron M, Makuwa M, Mahieux R, et al. Origin of HTLV-1 in hunters of nonhuman primates in Central Africa. J Infect Dis. 2015;211:361–5. · DOI
  19. Filippone C, Betsem E, Tortevoye P, Cassar O, Bassot S, Froment A, et al. A severe bite from a nonhuman primate is a major risk factor for HTLV-1 infection in hunters from Central Africa. Clin Infect Dis. 2015;60:1667–76. · DOI
  20. Guo HG, Wong-Stall F, Gallo RC. Novel viral sequences related to human T-cell leukemia virus in T cells of a seropositive baboon. Science. 1984;223:1195–7. · DOI
  21. Watanabe T, Seiki M, Tsujimoto H, Miyoshi I, Hayami M, Yoshida M. Sequence homology of the simian retrovirus genome with human T-cell leukemia virus type I. Virology. 1985;144:59–65. · DOI
  22. Sherman MP, Saksena NK, Dube DK, Yanagihara R, Poiesz BJ. Evolutionary insights on the origin of human T-cell lymphoma/leukemia virus type I (HTLV-I) derived from sequence analysis of a new HTLV-I variant from Papua New Guinea. J Virol. 1992;66:2556–63. · DOI
  23. Locatelli S, Peeters M. Cross-species transmission of simian retroviruses: how and why they could lead to the emergence of new diseases in the human population. AIDS. 2012;26:659–73. · DOI
  24. Turpin J, Alais S, Marçais A, Bruneau J, Melamed A, Gadot N, et al. Whole body clonality analysis in an aggressive STLV-1 associated leukemia (ATLL) reveals an unexpected clonal complexity. Cancer Lett. 2017;389:78–85. · DOI
  25. Afonso PV, Fagrouch Z, Deijs M, Niphuis H, Bogers W, Gessain A, et al. Absence of accessory genes in a divergent simian T-lymphotropic virus type 1 isolated from a bonnet macaque (Macaca radiata). PLoS Negl Trop Dis. 2019;13:e0007521. · DOI
  26. Lawrence JM, Cords M. Old World Monkeys. Nat Educ Knowl. 2012;3(7):13.
  27. Lowenstine LJ, Pedersen NC, Higgins J, Pallis KC, Uyeda A, Marx P, et al. Seroepidemiologic survey of captive Old-World primates for antibodies to human and simian retroviruses, and isolation of a lentivirus from sooty mangabeys (Cercocebus atys). Int J Cancer. 1986;38:563–74. · DOI
  28. Hunsmann G, Schneider J, Schmitt J, Yamamoto N. Detection of serum antibodies to adult T-cell leukemia virus in non-human primates and in people from Africa. Int J Cancer. 1983;32:329–32. · DOI
  29. Ishikawa K, Fukasawa M, Tsujimoto H, Else JG, Isahakia M, Ubhi NK, et al. Serological survey and virus isolation of simian T-cell leukemia/T-lymphotropic virus type I (STLV-I) in non-human primates in their native countries. Int J Cancer. 1987;40:233–9. · DOI
  30. Becker WB, Becker ML, Homma T, Brede HD, Kurth R. Serum antibodies to human T-cell leukaemia virus type I in different ethnic groups and in non-human primates in South Africa. S Afr Med J. 1985;67:445–9.
  31. Ishida T, Yamamoto K, Shotake T, Nozawa K, Hayami M, Hinuma Y. A field study of infection with human T-cell leukemia virus among African primates. Microbiol Immunol. 1986;30:315–21. · DOI
  32. Voevodin A, Samilchuk E, Allan J, Rogers J, Broussard S. Simian T-lymphotropic virus type 1 (STLV-1) infection in wild yellow baboons (Papio hamadryas cynocephalus) from Mikumi National Park, Tanzania. Virology. 1997;228:350–9. · DOI
  33. Moné J, Whitehead E, Leland M, Hubbard G, Allan JS. Simian T-cell leukemia virus type I infection in captive baboons. AIDS Res Hum Retroviruses. 1992;8:1653–61. · DOI
  34. Hayami M, Ishikawa K, Komuro A, Kawamoto Y, Nozawa K, Yamamoto K, et al. ATLV antibody in cynomolgus monkeys in the wild. Lancet. 1983;2:620. · DOI
  35. Yamamoto N, Hinuma Y, zur Hausen H, Schneider J, Hunsmann G. African green monkeys are infected with adult T-cell leukaemia virus or closely related agent. Lancet. 1983;1:240–1. · DOI
  36. Yamamoto N, Okada M, Hinuma Y, Hirsch FW, Chosa T, Schneider J, et al. Human adult T-cell leukaemia virus is distinct from a similar isolate of Japanese monkeys. J Gen Virol. 1984;65(Pt 12):2259–64. · DOI
  37. Yamamoto N, Kobayashi N, Takeuchi K, Koyanagi Y, Hatanaka M, Hinuma Y, et al. Characterization of African green monkey B-cell lines releasing an adult T-cell leukemia-virus-related agent. Int J Cancer. 1984;34:77–82. · DOI
  38. Botha MC, Jones M, de Klerk WA, Yamamoto N. Spread and distribution of human T-cell leukaemia virus type I-reactive antibody among baboons and monkeys in the northern and eastern Transvaal. S Afr Med J. 1985;67:665–8.
  39. Coursaget P, Barres JL, Yvonnet B, Chiron JP, Cornet M, Ferrara L, et al. Antibodies to human T-cell leukemia virus (HTLV-1) in non human primates from Senegal. Biomed Pharmacother. 1985;39:198–9.
  40. Dracopoli NC, Turner TR, Else JG, Jolly CJ, Anthony R, Gallo RC, et al. STLV-I antibodies in feral populations of East African vervet monkeys (Cercopithecus aethiops). Int J Cancer. 1986;38:523–9. · DOI
  41. Daniel MD, Letvin NL, Sehgal PK, Schmidt DK, Silva DP, Solomon KR, et al. Prevalence of antibodies to 3 retroviruses in a captive colony of macaque monkeys. Int J Cancer. 1988;41:601–8. · DOI
  42. Fultz PN, Gordon TP, Anderson DC, McClure HM. Prevalence of natural infection with simian immunodeficiency virus and simian T-cell leukemia virus type I in a breeding colony of sooty mangabey monkeys. AIDS. 1990;4:619–25. · DOI
  43. Estaquier J, Peeters M, Bedjabaga L, Honoré C, Bussi P, Dixson A, et al. Prevalence and transmission of simian immunodeficiency virus and simian T-cell leukemia virus in a semi-free-range breeding colony of mandrills in Gabon. AIDS. 1991;5:1385–6. · DOI
  44. Courgnaud V, Van Dooren S, Liegeois F, Pourrut X, Abela B, Loul S, et al. Simian T-cell leukemia virus (STLV) infection in wild primate populations in Cameroon: evidence for dual STLV type 1 and type 3 infection in agile mangabeys (Cercocebus agilis). J Virol. 2004;78:4700–9. · DOI
  45. Koralnik IJ, Boeri E, Saxinger WC, Monico AL, Fullen J, Gessain A, et al. Phylogenetic associations of human and simian T-cell leukemia/lymphotropic virus type I strains: evidence for interspecies transmission. J Virol. 1994;68:2693–707. · DOI
  46. Mahieux R, Pecon-Slattery J, Chen GM, Gessain A. Evolutionary inferences of novel simian T lymphotropic virus type 1 from Wild-Caught Chacma (Papio ursinus) and olive baboons (Papio anubis). Virology. 1998;251:71–84. · DOI
  47. Saksena NK, Herve V, Durand JP, Leguenno B, Diop OM, Digouette JP, et al. Seroepidemiologic, molecular, and phylogenetic analyses of simian T-cell leukemia viruses (STLV-I) from various naturally infected monkey species from central and western Africa. Virology. 1994;198:297–310. · DOI
  48. Schatzl H, Yakovleva L, Lapin B, Rose D, Inzhiia L, Gaedigk-Nitschko K, et al. Detection and characterization of T-cell leukemia virus-like proviral sequences in PBL and tissues of baboons by PCR. Leukemia. 1992;6(Suppl 3):158S–60S.
  49. Sintasath DM, Wolfe ND, LeBreton M, Jia H, Garcia AD, Diffo JLD, et al. Simian T-lymphotropic virus diversity among nonhuman primates, Cameroon. Emerg Infect Dis. 2009;15:175–84. · DOI
  50. Van Dooren S, Verschoor EJ, Fagrouch Z, Vandamme A-M. Phylogeny of primate T lymphotropic virus type 1 (PTLV-1) including various new Asian and African non-human primate strains. Infect Genet Evol. 2007;7:374–81. · DOI
  51. Seiki M, Hattori S, Hirayama Y, Yoshida M. Human adult T-cell leukemia virus: complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA. Proc Natl Acad Sci USA. 1983;80:3618–22. · DOI · Paper page
  52. Watanabe T, Seiki M, Yoshida M. HTLV type I (U. S. isolate) and ATLV (Japanese isolate) are the same species of human retrovirus. Virology. 1984;133:238–41. · DOI
  53. Voevodin AF, Johnson BK, Samilchuk EI, Stone GA, Druilhet R, Greer WJ, et al. Phylogenetic analysis of simian T-lymphotropic virus type I (STLV-I) in common chimpanzees (Pan troglodytes): evidence for interspecies transmission of the virus between chimpanzees and humans in Central Africa. Virology. 1997;238:212–20. · DOI
  54. Meertens L, Rigoulet J, Mauclère P, Van Beveren M, Chen GM, Diop O, et al. Molecular and phylogenetic analyses of 16 novel simian T cell leukemia virus type 1 from Africa: close relationship of STLV-1 from Allenopithecus nigroviridis to HTLV-1 subtype B strains. Virology. 2001;287:275–85. · DOI
  55. Ayouba A, Michem A, Peeters M, Vercammen F. Full-genome characterization of simian T-cell leukemia virus type 1 subtype b from a wild-born captive gorilla gorilla gorilla with T-cell lymphoma. Genome Announc. 2017;5:e01117-17. · DOI
  56. Mahieux R, Chappey C, Georges-Courbot MC, Dubreuil G, Mauclere P, Georges A, et al. Simian T-cell lymphotropic virus type 1 from Mandrillus sphinx as a simian counterpart of human T-cell lymphotropic virus type 1 subtype D. J Virol. 1998;72:10316–22. · DOI
  57. Makuwa M, Souquière S, Clifford SL, Telfer PT, Sallé B, Bourry O, et al. Two distinct STLV-1 subtypes infecting Mandrillus sphinx follow the geographic distribution of their hosts. AIDS Res Hum Retroviruses. 2004;20:1137–43. · DOI
  58. Liégeois F, Lafay B, Switzer WM, Locatelli S, Mpoudi-Ngolé E, Loul S, et al. Identification and molecular characterization of new STLV-1 and STLV-3 strains in wild-caught nonhuman primates in Cameroon. Virology. 2008;371:405–17. · DOI
  59. Van Dooren S, Salemi M, Vandamme AM. Dating the origin of the African human T-cell lymphotropic virus type-i (HTLV-I) subtypes. Mol Biol Evol. 2001;18:661–71. · DOI
  60. Mahieux R, Pecon-Slattery J, Gessain A. Molecular characterization and phylogenetic analyses of a new, highly divergent simian T-cell lymphotropic virus type 1 (STLV-1marc1) in Macaca arctoides. J Virol. 1997;71:6253–8. · DOI
  61. Ibrahim F, de Thé G, Gessain A. Isolation and characterization of a new simian T-cell leukemia virus type 1 from naturally infected celebes macaques (Macaca tonkeana): complete nucleotide sequence and phylogenetic relationship with the Australo-Melanesian human T-cell leukemia virus type 1. J Virol. 1995;69:6980–93. · DOI
  62. Van Dooren S, Meertens L, Lemey P, Gessain A, Vandamme A-M. Full-genome analysis of a highly divergent simian T-cell lymphotropic virus type 1 strain in Macaca arctoides. J Gen Virol. 2005;86:1953–9. · DOI
  63. Calvignac S, Terme J-M, Hensley SM, Jalinot P, Greenwood AD, Hänni C. Ancient DNA identification of early 20th century simian T-cell leukemia virus type 1. Mol Biol Evol. 2008;25:1093–8. · DOI
  64. Niphuis H, Verschoor EJ, Bontjer I, Peeters M, Heeney JL. Reduced transmission and prevalence of simian T-cell lymphotropic virus in a closed breeding colony of chimpanzees (Pan troglodytes verus). J Gen Virol. 2003;84:615–20. · DOI
  65. Leendertz FH, Junglen S, Boesch C, Formenty P, Couacy-Hymann E, Courgnaud V, et al. High variety of different simian T-cell leukemia virus type 1 strains in chimpanzees (Pan troglodytes verus) of the Taï National Park, Côte d’Ivoire. J Virol. 2004;78:4352–6. · DOI
  66. d’Offay JM, Eberle R, Sucol Y, Schoelkopf L, White MA, Valentine BD, et al. Transmission dynamics of simian T-lymphotropic virus type 1 (STLV1) in a baboon breeding colony: predominance of female-to-female transmission. Comp Med. 2007;57:105–14.
  67. Nerrienet E, Amouretti X, Müller-Trutwin MC, Poaty-Mavoungou V, Bedjebaga I, Nguyen HT, et al. Phylogenetic analysis of SIV and STLV type I in mandrills (Mandrillus sphinx): indications that intracolony transmissions are predominantly the result of male-to-male aggressive contacts. AIDS Res Hum Retroviruses. 1998;14:785–96. · DOI
  68. Roussel M, Pontier D, Ngoubangoye B, Kazanji M, Verrier D, Fouchet D. Modes of transmission of simian T-lymphotropic virus type 1 in semi-captive mandrills (Mandrillus sphinx). Vet Microbiol. 2015;179:155–61. · DOI
  69. Allan JS, Leland M, Broussard S, Mone J, Hubbard G. Simian T-cell lymphotropic viruses (STLVs) and lymphomas in african nonhuman primates. Cancer Invest. 2001;19:383–95. · DOI
  70. Enose-Akahata Y, Caruso B, Haner B, Charlip E, Nair G, Massoud R, et al. Development of neurologic diseases in a patient with primate T lymphotropic virus type 1 (PTLV-1). Retrovirology. 2016;13:56. · DOI
  71. Salemi M, Van Dooren S, Audenaert E, Delaporte E, Goubau P, Desmyter J, et al. Two new human T-lymphotropic virus type I phylogenetic subtypes in seroindeterminates, a Mbuti pygmy and a Gabonese, have closest relatives among African STLV-I strains. Virology. 1998;246:277–87. · DOI
  72. Touzé E, Gessain A, Lyon-Caen O, Gout O. Tropical spastic paraparesis/HTLV-I-associated myelopathy in Europe and in Africa: clinical and epidemiologic aspects. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;13(Suppl 1):S38–45. · DOI
  73. Noda Y, Ishikawa K, Sasagawa A, Honjo S, Mori S, Tsujimoto H, et al. Hematologic abnormalities similar to the preleukemic state of adult T-cell leukemia in African green monkeys naturally infected with simian T-cell leukemia virus. Jpn J Cancer Res. 1986;77:1227–34.
  74. Sakakibara I, Sugimoto Y, Sasagawa A, Honjo S, Tsujimoto H, Nakamura H, et al. Spontaneous malignant lymphoma in an African green monkey naturally infected with simian T-lymphotropic virus (STLV). J Med Primatol. 1986;15:311–8. · DOI
  75. Tsujimoto H, Noda Y, Ishikawa K, Nakamura H, Fukasawa M, Sakakibara I, et al. Development of adult T-cell leukemia-like disease in African green monkey associated with clonal integration of simian T-cell leukemia virus type I. Cancer Res. 1987;47:269–74.
  76. McCarthy TJ, Kennedy JL, Blakeslee JR, Bennett BT. Spontaneous malignant lymphoma and leukemia in a simian T-lymphotropic virus type I (STLV-I) antibody positive olive baboon. Lab Anim Sci. 1990;40:79–81.
  77. Hubbard GB, Moné JP, Allan JS, Davis KJ, Leland MM, Banks PM, et al. Spontaneously generated non-Hodgkin’s lymphoma in twenty-seven simian T-cell leukemia virus type 1 antibody-positive baboons (Papio species). Lab Anim Sci. 1993;43:301–9.
  78. d’Offay JM, Eberle R, Wolf RF, Kosanke SD, Doocy KR, Ayalew S, et al. Simian T-lymphotropic Virus-associated lymphoma in 2 naturally infected baboons: T-cell clonal expansion and immune response during tumor development. Comp Med. 2013;63:288–94.
  79. Miura M, Yasunaga J, Tanabe J, Sugata K, Zhao T, Ma G, et al. Characterization of simian T-cell leukemia virus type 1 in naturally infected Japanese macaques as a model of HTLV-1 infection. Retrovirology. 2013;10:118. · DOI
  80. Homma T, Kanki PJ, King NW, Hunt RD, O’Connell MJ, Letvin NL, et al. Lymphoma in macaques: association with virus of human T lymphotrophic family. Science. 1984;225:716–8. · DOI
  81. Srivastava BI, Wong-Staal F, Getchell JP. Human T-cell leukemia virus I provirus and antibodies in a captive gorilla with non-Hodgkin’s lymphoma. Cancer Res. 1986;46:4756–8.
  82. Voevodin AF, Lapin BA, Yakovleva LA, Ponomaryeva TI, Oganyan TE, Razmadze EN. Antibodies reacting with human T-lymphotropic retrovirus (HTLV-I) or related antigens in lymphomatous and healthy hamadryas baboons. Int J Cancer. 1985;36:579–84. · DOI
  83. Ma G, Yasunaga J, Akari H, Matsuoka M. TCF1 and LEF1 act as T-cell intrinsic HTLV-1 antagonists by targeting Tax. Proc Natl Acad Sci USA. 2015;112:2216–21. · DOI
  84. Castro I, Giret TM, Magnani DM, Maxwell HS, Umland O, Perry JK, et al. Cellular immune responses against simian T-lymphotropic virus type 1 target tax in infected baboons. J Virol. 2016;90:5280–91. · DOI
  85. Termini JM, Magnani DM, Maxwell HS, Lauer W, Castro I, Pecotte J, et al. Simian T lymphotropic virus 1 infection of Papio anubis: tax sequence heterogeneity and T cell recognition. J Virol. 2017;91:e00950-17. · DOI
  86. Yee JL, Montiel NA, Ardeshir A, Ardeshr A, Lerche NW. Constitutive release of IFNγ and IL2 from peripheral blood mononuclear cells of rhesus macaques (Macaca mulatta) infected with simian T-lymphotropic virus type 1. Comp Med. 2013;63:508–14.
  87. Souquière S, Mouinga-Ondemé A, Makuwa M, Hermine O, Kazanji M. Dynamic interaction between STLV-1 proviral load and T-cell response during chronic infection and after immunosuppression in non-human primates. PLoS ONE. 2009;4:e6050. · DOI
  88. Sugata K, Yasunaga J-I, Miura M, Akari H, Utsunomiya A, Nosaka K, et al. Enhancement of anti-STLV-1/HTLV-1 immune responses through multimodal effects of anti-CCR4 antibody. Sci Rep. 2016;6:27150. · DOI
  89. Souquière S, Mouinga-Ondeme A, Makuwa M, Beggio P, Radaelli A, De Giuli Morghen C, et al. T-cell tropism of simian T-cell leukaemia virus type 1 and cytokine profiles in relation to proviral load and immunological changes during chronic infection of naturally infected mandrills (Mandrillus sphinx). J Med Primatol. 2009;38:279–89. · DOI
  90. Datta A, Bellon M, Sinha-Datta U, Bazarbachi A, Lepelletier Y, Canioni D, et al. Persistent inhibition of telomerase reprograms adult T-cell leukemia to p53-dependent senescence. Blood. 2006;108:1021–9. · DOI · Paper page
  91. Afonso PV, Mekaouche M, Mortreux F, Toulza F, Moriceau A, Wattel E, et al. Highly active antiretroviral treatment against STLV-1 infection combining reverse transcriptase and HDAC inhibitors. Blood. 2010;116:3802–8. · DOI
  92. Voevodin A, Samilchuk E, Schätzl H, Boeri E, Franchini G. Interspecies transmission of macaque simian T-cell leukemia/lymphoma virus type 1 in baboons resulted in an outbreak of malignant lymphoma. J Virol. 1996;70:1633–9. · DOI
  93. Dube S, Saksena N, Spicer T, Healey J, Benz P, Dube DK, et al. Delayed seroconversion to STLV-1 infection is associated with mutations in the pol and rex genes. Virol J. 2013;10:282. · DOI
  94. McGinn TM, Tao B, Cartner S, Schoeb T, Davis I, Ratner L, et al. Association of primate T-cell lymphotropic virus infection of pig-tailed macaques with high mortality. Virology. 2002;304:364–78. · DOI
  95. Kazanji M, Moreau JP, Mahieux R, Bonnemains B, Bomford R, Gessain A, et al. HTLV-I infection in squirrel monkeys (Saïmiri sciureus) using autologous, homologous, or heterologous HTLV-I-transformed cell lines. Virology. 1997;231:258–66. · DOI
  96. Kazanji M, Ureta-Vidal A, Ozden S, Tangy F, de Thoisy B, Fiette L, et al. Lymphoid organs as a major reservoir for human T-cell leukemia virus type 1 in experimentally infected squirrel monkeys (Saimiri sciureus): provirus expression, persistence, and humoral and cellular immune responses. J Virol. 2000;74:4860–7. · DOI
  97. Kazanji M, Heraud J-M, Merien F, Pique C, de Thé G, Gessain A, et al. Chimeric peptide vaccine composed of B- and T-cell epitopes of human T-cell leukemia virus type 1 induces humoral and cellular immune responses and reduces the proviral load in immunized squirrel monkeys (Saimiri sciureus). J Gen Virol. 2006;87:1331–7. · DOI
  98. Mortreux F, Kazanji M, Gabet AS, de Thoisy B, Wattel E. Two-step nature of human T-cell leukemia virus type 1 replication in experimentally infected squirrel monkeys (Saimiri sciureus). J Virol. 2001;75:1083–9. · DOI
  99. Debacq C, Héraud J-M, Asquith B, Bangham C, Merien F, Moules V, et al. Reduced cell turnover in lymphocytic monkeys infected by human T-lymphotropic virus type 1. Oncogene. 2005;24:7514–23. · DOI
  100. Heraud JM, Mortreux F, Merien F, Contamin H, Mahieux R, Pouliquen JF, et al. The efficacy of combined therapy of arsenic trioxide and alpha interferon in human T-cell leukemia virus type-1-infected squirrel monkeys (Saimiri sciureus). Antiviral Res. 2006;70:132–9. · DOI
  101. Pise-Masison CA, de Castro-Amarante MF, Enose-Akahata Y, Buchmann RC, Fenizia C, Washington Parks R, et al. Co-dependence of HTLV-1 p12 and p8 functions in virus persistence. PLoS Pathog. 2014;10:e1004454. · DOI
  102. Valeri VW, Hryniewicz A, Andresen V, Jones K, Fenizia C, Bialuk I, et al. Requirement of the human T-cell leukemia virus p12 and p30 products for infectivity of human dendritic cells and macaques but not rabbits. Blood. 2010;116:3809–17. · DOI
  103. McGinn TM, Wei Q, Stallworth J, Fultz PN. Immune responses to HTLV-I(ACH) during acute infection of pig-tailed macaques. AIDS Res Hum Retroviruses. 2004;20:443–56. · DOI
  104. Bai XT, Nicot C. Overview on HTLV-1 p12, p8, p30, p13: accomplices in persistent infection and viral pathogenesis. Front Microbiol. 2012;3:400. · DOI
  105. Anupam R, Doueiri R, Green PL. The need to accessorize: molecular roles of HTLV-1 p30 and HTLV-2 p28 accessory proteins in the viral life cycle. Front Microbiol. 2013;4:275. · DOI
  106. Beilke MA, Theall KP, O’Brien M, Clayton JL, Benjamin SM, Winsor EL, et al. Clinical outcomes and disease progression among patients coinfected with HIV and human T lymphotropic virus types 1 and 2. Clin Infect Dis. 2004;39:256–63. · DOI
  107. Oo Z, Barrios CS, Castillo L, Beilke MA. High levels of CC-chemokine expression and downregulated levels of CCR5 during HIV-1/HTLV-1 and HIV-1/HTLV-2 coinfections: CC-chemokines and CCR5 levels during HIV/HTLV coinfections. J Med Virol. 2015;87:790–7. · DOI
  108. Switzer WM, Garcia AD, Yang C, Wright A, Kalish ML, Folks TM, et al. Coinfection with HIV-1 and simian foamy virus in West Central Africans. J Infect Dis. 2008;197:1389–93. · DOI
  109. Switzer WM, Tang S, Zheng H, Shankar A, Sprinkle PS, Sullivan V, et al. Dual simian foamy virus/human immunodeficiency virus type 1 infections in persons from Côte d’Ivoire. PLoS ONE. 2016;11:e0157709. · DOI
  110. Souquière S, Makuwa M, Sallé B, Lepelletier Y, Mortreux F, Hermine O, et al. Immunological alterations and associated diseases in mandrills (Mandrillus sphinx) naturally co-infected with SIV and STLV. Virology. 2014;454–455:184–96. · DOI
  111. Traina-Dorge VL, Martin LN, Lorino R, Winsor EL, Beilke MA. Human T cell leukemia virus type 1 up-regulation after simian immunodeficiency virus-1 coinfection in the nonhuman primate. J Infect Dis. 2007;195:562–71. · DOI
  112. Harrison LH, Quinn TC, Schechter M. Human T cell lymphotropic virus type I does not increase human immunodeficiency virus viral load in vivo. J Infect Dis. 1997;175:438–40. · DOI
  113. Goldberg TL, Sintasath DM, Chapman CA, Cameron KM, Karesh WB, Tang S, et al. Coinfection of ugandan red colobus (Procolobus [Piliocolobus] rufomitratus tephrosceles) with novel, divergent delta-, lenti-, and spumaretroviruses. J Virol. 2009;83:11318–29. · DOI
  114. Durand JP, Tuppin P, Maison P, Galat G, Galat-Luong A, Jeannel D, et al. Increased risk for a second retroviral infection (SIV or STLV type I) for wild African green monkeys already infected by one retrovirus in Senegal (West Africa). AIDS Res Hum Retroviruses. 1995;11:985–8. · DOI
  115. Beilke MA, Dorge VLT, Sirois M, Bhuiyan A, Murphy EL, Walls JM, et al. Relationship between human T lymphotropic virus (HTLV) type 1/2 viral burden and clinical and treatment parameters among patients with HIV type 1 and HTLV-1/2 coinfection. Clin Infect Dis. 2007;44:1229–34. · DOI
  116. Beilke MA, Japa S, Moeller-Hadi C, Martin-Schild S. Tropical spastic paraparesis/human T leukemia virus type 1-associated myelopathy in HIV type 1-coinfected patients. Clin Infect Dis. 2005;41:e57–63. · DOI
  117. Casseb J, Posada-Vergara MP, Montanheiro P, Fukumori LMI, Olah I, Smid J, et al. T CD4+ cells count among patients co-infected with human immunodeficiency virus type 1 (HIV-1) and human T-cell leukemia virus type 1 (HTLV-1): high prevalence of tropical spastic paraparesis/HTLV-1-associated myelopathy (TSP/HAM). Revista do Instituto de Medicina Tropical de São Paulo. 2007;49:231–3. · DOI
  118. Casseb J, de Oliveira ACP, Vergara MPP, Montanheiro P, Bonasser F, Meilman Ferreira C, et al. Presence of tropical spastic paraparesis/human T-cell lymphotropic virus type 1-associated myelopathy (TSP/HAM)-like among HIV-1-infected patients. J Med Virol. 2008;80:392–8. · DOI
  119. Casoli C, Pilotti E, Bertazzoni U. Molecular and cellular interactions of HIV-1/HTLV coinfection and impact on AIDS progression. AIDS Rev. 2007;9:140–9.
  120. Rahimi H, Rezaee SA, Valizade N, Vakili R, Rafatpanah H. Assessment of HTLV-I proviral load, HIV viral load and CD4 T cell count in infected subjects; with an emphasis on viral replication in co-infection. Iran J Basic Med Sci. 2014;17:49–54.
  121. Fultz PN, Su L, May P, West JT. Isolation of sooty mangabey simian T-cell leukemia virus type I [STLV-I(sm)] and characterization of a mangabey T-cell line coinfected with STLV-I(sm) and simian immunodeficiency virus SIVsmmPBj14. Virology. 1997;235:271–85. · DOI
  122. Traina-Dorge V, Blanchard J, Martin L, Murphey-Corb M. Immunodeficiency and lymphoproliferative disease in an African green monkey dually infected with SIV and STLV-I. AIDS Res Hum Retroviruses. 1992;8:97–100. · DOI
  123. Alais S, Pasquier A, Jegado B, Journo C, Rua R, Gessain A, et al. STLV-1 co-infection is correlated with an increased SFV proviral load in the peripheral blood of SFV/STLV-1 naturally infected non-human primates. PLoS Negl Trop Dis. 2018;12:e0006812. · DOI

Cited by

Sorted by citations

See all 27

Metadata

Authors
Jégado, B., Kashanchi, F., Dutartre, H., & Mahieux, R.
Venue
Retrovirology
Published
2019-12
Volume
16
Issue
1
ISSN
1742-4690
Cited by
27
References
1
Language
en
Funders
  • FRM (DEQ20180339200)
  • labex (ANR-11-LABX-0048)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review